The TAR versus arthrodesis (TARVA) trial aims to compare the clinical and cost-effectiveness of TAR against ankle arthrodesis in the treatment of end-stage ankle OA in patients aged 50–85 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback